Consolidated net profit before minority interest stood at EGP 201,131,077 in the January-September 2020, compared to EGP 70,923,877 achieved in the prior-year period.
On May 25th, the company's ordinary general meeting approved the distribution of a total of EGP 73,760,640 worth of dividends.
Minapharm Pharmaceuticals is an Egypt-based company engaged in the production and distribution of pharmaceutical products. It is in cooperation with several international pharmaceutical companies and it distributes its products within and outside Egypt.
Copyright © 2020 Arab Finance Brokerage Company All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info).